Back
Galectin Therapeutics Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
47
GALT
Galectin Therapeutics
Last Price:
3.15
Seasonality Move:
-7.91%
Buy
61
MDGL
Madrigal Pharmaceuticals
Last Price:
217.01
Seasonality Move:
-8.39%
Sell
47
Galectin Therapeutics (GALT)
is a Sell
Is Galectin Therapeutics a Buy, Sell or Hold?
- The current Galectin Therapeutics [GALT] share price is $3.06. The Score for GALT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- GALT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $211.73. The Score for MDGL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GALT Stock Price Chart
What is Galectin Therapeutics's stock price today?
-
The Galectin Therapeutics share price today is $3.06
The current trend is relatively stagnant and GALT is experiencing buying pressure, which is a positive indicator for future bullish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $211.73
The current trend is relatively stagnant and MDGL is experiencing selling pressure, which indicates risk of future bearish movement.
GALT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 46.21 | Sell |
| Chaikin Money Flow: | 88261 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.1 - 3.7) | Sell |
| Bollinger Bands (100): | (1.61 - 3.11) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.9 | Sell |
| Relative Strength Index (14 RSI): | 45.18 | Sell |
| Chaikin Money Flow: | -254611 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (202.77 - 229.47) | Sell |
| Bollinger Bands (100): | (211.39 - 251.49) | Sell |
GALT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.16 | Sell |
| 20-day SMA: | 3.3 | Sell |
| 50-day SMA: | 2.96 | Buy |
| 200-day SMA: | 2.1 | Buy |
| 8-day EMA: | 3.13 | Sell |
| 20-day EMA: | 3.22 | Sell |
| 50-day EMA: | 2.98 | Buy |
| 200-day EMA: | 2.27 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 213.56 | Sell |
| 20-day SMA: | 211.43 | Buy |
| 50-day SMA: | 235.63 | Sell |
| 200-day SMA: | 201.57 | Buy |
| 8-day EMA: | 211.8 | Sell |
| 20-day EMA: | 216.08 | Sell |
| 50-day EMA: | 224.86 | Sell |
| 200-day EMA: | 215.85 | Sell |
Galectin Therapeutics Earnings Growth & GALT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $2.35 per share, an increase next quarter of $1.27 per share, a decrease this year of $9.09 per share, and an increase next year of $10.64 per share.
Galectin Therapeutics Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||